Brendan C. Lanpher, M.D.

Closed for Enrollment

• Investigation of Hyperammonemia in Patients Status Post Roux-en-Y Gastric Bypass Surgery Rochester, Minn.

  The purpose of this study is to determine plasma levels of Peptide YY  (PYY), ghrelin, ammonia, and amino acids prior to and after Roux-en-Y gastric bypass surgery.

• Research for Individualized Therapeutics in Rare Genetic Disease Rochester, Minn., Scottsdale/Phoenix, Ariz., Jacksonville, Fla.

  The purpose of this study is to identify patients with rare genetic disorders that may potentially benefit from an ASO therapeutic based on the characteristics of their genetic disease and the causative genetic alterations and seek the research and development opportunities to have them developed, to have the safety and toxicity studies performed with the ultimate goal of treating the individual in a future N of 1 clinical trial.